Articles:
Publications:

3 hours ago

Ebola in the DRC: Four Vaccines Against The Bundibugyo Strain Could Be Available Within Three Months-WHO

Ebola in the DRC: Four Vaccines Against The Bundibugyo Strain Could Be Available Within Three Months-WHO

By Jean-Pierre A. Research are progressing in the fight against the ongoing Ebola virus disease outbreak in the DRC. Four vaccine candidates against the Bundibugyo strain are currently undergoing clinical trials and could be available in about... Read more.

More from Pan African Visions

Pan African Visions 3 hours ago
Turn on Transparency.
The Exercise Of Constitutional Power In Uganda: My Response To Asuman Kiyingi
Owner: Ajong Mbapndah More info
Pan African Visions 3 hours ago
Turn on Transparency.
Uganda National Media Group Relaunches After Restructuring, Targets Digital News Market
Owner: Ajong Mbapndah More info
Pan African Visions 3 hours ago
Turn on Transparency.
Ebola in the DRC: Four Vaccines Against The Bundibugyo Strain Could Be Available Within Three Months-WHO
Owner: Ajong Mbapndah More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 10, 2026
The Washington Post Joins Trump's Growing List of Media Lawsuit Losses
Neutral | Owner: The Poynter Institute for Media Studies
Jul. 10, 2026
Hackers Published Private Messages They Attribute to Journalist and Media Executive Ksenia Sobchak, Pointing to Supposed 'Agreements' Between Her Media Empire and Russian Officials
Neutral | Owner: Galina Timchenko
Jul. 10, 2026
Greek Roma Activist's Magazine Aims to Showcase 'Unknown History'
Neutral | Owner: Balkan Investigative Reporting Network

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more